Which antibiotics are associated with Stevens-Johnson syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotics Associated with Stevens-Johnson Syndrome

Sulfonamide antibiotics are the most common antibiotics causing Stevens-Johnson syndrome (SJS), followed by penicillins, cephalosporins, fluoroquinolones, and macrolides. 1

High-Risk Antibiotics for SJS/TEN

Based on the most recent and comprehensive evidence, antibiotics associated with SJS/TEN include:

  1. Sulfonamide antibiotics (highest risk):

    • Trimethoprim-sulfamethoxazole (co-trimoxazole)
    • Other sulfonamide antibiotics 2, 1
  2. Beta-lactam antibiotics:

    • Penicillins (including amoxicillin and amoxicillin-clavulanate) 3, 1, 4
    • Aminopenicillins
    • Cephalosporins 1, 5
  3. Other antibiotics:

    • Fluoroquinolones 1
    • Macrolides 1

Prevalence and Risk Assessment

According to the most recent systematic review and meta-analysis (2023), antibiotics are associated with 28% of all SJS/TEN cases worldwide 1. Among antibiotic-associated SJS/TEN:

  • Sulfonamides: 32% of cases
  • Penicillins: 22% of cases
  • Cephalosporins: 11% of cases
  • Fluoroquinolones: 4% of cases
  • Macrolides: 2% of cases

Clinical Implications and Management

Recognition and Prevention

  • SJS/TEN typically develops 5-28 days after starting a new medication 2
  • Risk is higher in patients with previous drug hypersensitivity reactions to the same or similar drugs
  • Genetic factors may increase susceptibility (e.g., HLA-B*1502 and carbamazepine in Han Chinese) 2, 5

Warning Signs of SJS/TEN

  • Mucocutaneous tenderness
  • Hemorrhagic erosions
  • Erythema
  • Epidermal detachment (blisters and denuded skin)
  • Fever and flu-like symptoms often precede skin manifestations

Management of Suspected SJS/TEN

  1. Immediate discontinuation of the suspected causative antibiotic 2
  2. Urgent referral to specialized care (dermatology, burn center, or ICU) 2
  3. Assessment of prognosis using SCORTEN 2
  4. Supportive care and consideration of immunomodulating therapies

Special Considerations

Pediatric Patients

  • In children, antibiotics and anticonvulsants are the most common causes of SJS/TEN 2
  • Mycoplasma pneumoniae infection is a significant non-drug cause of SJS in children 2

Alternative Antibiotics

When treating patients with a history of SJS/TEN:

  • Avoid the culprit antibiotic and structurally similar drugs
  • Consider patch testing or T-cell proliferation assays in specialized centers to confirm the causative agent 2
  • Choose antibiotics from a different class with no cross-reactivity

Pitfalls and Caveats

  1. Delayed recognition: Early signs of SJS/TEN may be mistaken for common drug rashes or viral exanthems. Progressive mucosal involvement and skin pain (rather than itch) are concerning features.

  2. Confounding factors: Paracetamol and ibuprofen are often considered as potential causes but may be confounders as they're frequently used to treat prodromal symptoms of SJS/TEN 2.

  3. Infection vs. drug cause: Some cases of SJS/TEN, especially in children, may be triggered by infections rather than medications. Mycoplasma pneumoniae and Herpes simplex virus are documented causes 2, 5.

  4. Mortality risk: SJS has a mortality rate of 1-5%, while TEN has a mortality rate of 25-35% 5. Prompt recognition and management are critical to improve outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.